Evidence map›Paper›PMID 42374575›Full record

ArticleEpigenetics & chromatin2026

CancerSubtyper: a deep learning framework for cancer subtyping through DNA methylation data.

Joung Min Choi, Yat Fei Cheung, Liqing Zhang

Abstract read
In one paragraph

Article in Epigenetics & chromatin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Joung Min Choi *Department of Computer Science, Virginia Tech, Blacksburg, VA, 24061, USA.
Yat Fei Cheung *Department of Computer Science, Virginia Tech, Blacksburg, VA, 24061, USA.
Liqing ZhangDepartment of Computer Science, Virginia Tech, Blacksburg, VA, 24061, USA. lqzhang@cs.vt.edu.

Funding

Community Reservoirs of Extended-Spectrum Beta-Lactamase-producing and Multi-Drug Resistant EnterobacteralesR01AI179686 · NIAID · EMORY UNIVERSITY · PI Latania K. Logan · 2024 to 2026
$2.3M
National Science Foundation 2004751NIAID NIH HHS R01 AI179686NIH HHS 1R01AI179686-01A1
6 · The paper itself

Abstract

backgroundMolecular subtyping is essential for precision oncology, enabling the classification of tumors into biologically and clinically relevant categories. DNA methylation has emerged as a promising biomarker for cancer subtyping, yet its application remains limited by high dimensionality, batch effects, and the lack of automated, user-friendly analytical tools.

resultsHere, we present CancerSubtyper, an end-to-end computational framework for deep learning-based cancer subtyping using DNA methylation data, which is accessible through an intuitive web interface designed to support interactive exploration and downstream analysis. CancerSubtyper integrates two complementary models: a semi-supervised classifier for cancers with well-established subtypes, and a hybrid framework that integrates supervised and unsupervised learning to identify novel subtypes. The framework automatically performs preprocessing, feature selection, batch correction, and cancer subtyping while offering interactive visualization for subtype exploration and validation.

conclusionBy providing an automated, end-to-end workflow accessible through a user-friendly web interface, CancerSubtyper lowers the barrier to large-scale methylation analysis and provides a powerful tool for molecular subtyping and precision oncology research. The framework is freely accessible at https://github.com/ycheung5/cancersubtyper/ .

Indexed as

Deep LearningDNA MethylationNeoplasmsSoftwareHumansDeep learningDNA methylationMolecular cancer subtyping

Identifiers

PMID42374575
PMCPMC13576342

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.